|
AU2011349446C1
(en)
|
2010-12-22 |
2016-01-21 |
Fate Therapauetics, Inc. |
Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
|
|
EP2951290B1
(en)
|
2013-02-01 |
2017-11-29 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Method for generating retinal pigment epithelium (rpe) cells from induced pluripotent stem cells (ipscs)
|
|
WO2014124087A1
(en)
|
2013-02-06 |
2014-08-14 |
University Of Rochester |
Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders
|
|
SG11201606934SA
(en)
|
2014-03-04 |
2016-09-29 |
Fate Therapeutics Inc |
Improved reprogramming methods and cell culture platforms
|
|
US9724432B2
(en)
|
2015-04-30 |
2017-08-08 |
University Of Rochester |
Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
|
|
CA2997763A1
(en)
|
2015-09-08 |
2017-03-16 |
Cellular Dynamics International, Inc. |
Macs-based purification of stem cell-derived retinal pigment epithelium
|
|
KR102781602B1
(ko)
|
2015-09-08 |
2025-03-18 |
더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 |
임상 등급 망막 색소 상피 세포의 재현성 있는 분화 방법
|
|
CA3001917A1
(en)
|
2015-10-16 |
2017-04-20 |
Fate Therapeutics, Inc. |
Platform for the induction & maintenance of ground state pluripotency
|
|
ES2862676T3
(es)
|
2015-10-20 |
2021-10-07 |
Fujifilm Cellular Dynamics Inc |
Producción de células precursoras hematopoyéticas multilinaje mediante programación genética
|
|
JP7099967B2
(ja)
|
2016-07-01 |
2022-07-12 |
リサーチ ディベロップメント ファウンデーション |
幹細胞由来移植片からの増殖性細胞の排除
|
|
US11866733B2
(en)
|
2016-08-01 |
2024-01-09 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Human induced pluripotent stem cells for high efficiency genetic engineering
|
|
EP3523422B1
(en)
|
2016-10-05 |
2024-12-25 |
FUJIFILM Cellular Dynamics, Inc. |
Generating mature lineages from induced pluripotent stem cells with mecp2 disruption
|
|
AU2017359330B2
(en)
|
2016-11-09 |
2022-03-10 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Services |
3D vascularized human ocular tissue for cell therapy and drug discovery
|
|
EP3583201B1
(en)
|
2017-02-14 |
2024-01-17 |
University of Pittsburgh - Of the Commonwealth System of Higher Education |
Methods of engineering human induced pluripotent stem cells to produce liver tissue
|
|
AU2018254442B2
(en)
|
2017-04-18 |
2024-03-28 |
FUJIFILM Cellular Dynamics, Inc. |
Antigen-specific immune effector cells
|
|
JP7457505B2
(ja)
|
2017-05-10 |
2024-03-28 |
ユニバーシティー オブ ロチェスター |
神経精神障害を処置する方法
|
|
AU2019256723B2
(en)
|
2018-04-20 |
2025-09-04 |
FUJIFILM Cellular Dynamics, Inc. |
Method for differentiation of ocular cells and use thereof
|
|
CA3103663A1
(en)
|
2018-06-18 |
2019-12-26 |
University Of Rochester |
Inhibition of re1-silencing transcription factor in the treatment of schizophrenia and other neuropsychiatric disorders
|
|
KR20210054502A
(ko)
|
2018-06-21 |
2021-05-13 |
유니버시티 오브 로체스터 |
헌팅턴병을 치료하거나 이의 발병을 저해하는 방법
|
|
JP7718819B2
(ja)
*
|
2018-07-02 |
2025-08-05 |
リン、シー－ラン |
成体幹細胞の拡大と誘導のインビトロでの誘発
|
|
IL282791B2
(en)
|
2018-11-19 |
2026-03-01 |
Us Health |
Biodegradable tissue replacement implant and its use
|
|
AU2019386140A1
(en)
|
2018-11-28 |
2021-06-24 |
Board Of Regents, The University Of Texas System |
Multiplex genome editing of immune cells to enhance functionality and resistance to suppressive environment
|
|
WO2020112493A1
(en)
|
2018-11-29 |
2020-06-04 |
Board Of Regents, The University Of Texas System |
Methods for ex vivo expansion of natural killer cells and use thereof
|
|
CA3122289A1
(en)
|
2018-12-11 |
2020-06-18 |
University Of Rochester |
Methods of treating schizophrenia and other neuropsychiatric disorders
|
|
WO2020167822A2
(en)
|
2019-02-13 |
2020-08-20 |
University Of Rochester |
Gene networks that mediate remyelination of the human brain
|
|
AU2021235185A1
(en)
|
2020-03-09 |
2022-11-03 |
Fujifilm Corporation |
Markers specific for pluripotent stem cells, and methods of using the same
|
|
BR112022024064A2
(pt)
|
2020-05-29 |
2023-01-31 |
Fujifilm Cellular Dynamics Inc |
Bicamada de epitélio pigmentado da retina e fotorreceptores e uso dos mesmos
|
|
PH12022552993A1
(en)
|
2020-05-29 |
2023-01-16 |
Fujifilm Cellular Dynamics Inc |
Retinal pigmented epithelium and photoreceptor dual cell aggregates and methods of use thereof
|
|
EP4243839A1
(en)
|
2020-11-13 |
2023-09-20 |
Catamaran Bio, Inc. |
Genetically modified natural killer cells and methods of use thereof
|
|
AU2021381011B2
(en)
|
2020-11-18 |
2025-04-10 |
Assistance Publique - Hopitaux De Paris |
Generation of secretome-containing compositions, and methods of using and analyzing the same
|
|
CA3199729A1
(en)
|
2020-11-24 |
2022-06-02 |
Monash University |
Induced stem cells
|
|
CA3199728A1
(en)
|
2020-11-24 |
2022-06-02 |
Jose POLO |
Methods and cellular structures
|
|
AU2021388155A1
(en)
|
2020-11-25 |
2023-06-15 |
Catamaran Bio, Inc. |
Cellular therapeutics engineered with signal modulators and methods of use thereof
|
|
IL306134A
(en)
|
2021-03-25 |
2023-11-01 |
Bluerock Therapeutics Lp |
Methods for obtaining induced pluripotent stem cells
|
|
WO2022251443A1
(en)
|
2021-05-26 |
2022-12-01 |
FUJIFILM Cellular Dynamics, Inc. |
Methods to prevent rapid silencing of genes in pluripotent stem cells
|
|
ES3064924T3
(en)
|
2021-05-28 |
2026-04-30 |
Us Health |
Biodegradable tissue scaffold with secondary matrix to host weakly adherent cells
|
|
JP2024520424A
(ja)
|
2021-05-28 |
2024-05-24 |
ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
黄斑、中心および末梢網膜色素上皮細胞を生成する方法
|
|
EP4402249A1
(en)
|
2021-09-13 |
2024-07-24 |
Fujifilm Cellular Dynamics, Inc. |
Methods for the production of committed cardiac progenitor cells
|
|
CA3235105A1
(en)
|
2021-10-20 |
2023-04-27 |
Steven A. Goldman |
Humanized chimeras for the prospective assessment of glial cell addition or replacement therapy
|
|
WO2023069881A1
(en)
|
2021-10-20 |
2023-04-27 |
University Of Rochester |
Treatment with genetically modified cells, and genetically modified cells per se, with increased competitive advantage and/or decreased competitive disadvantage
|
|
AU2022368907A1
(en)
|
2021-10-20 |
2024-05-02 |
University Of Copenhagen |
Rejuvenation treatment of age-related white matter loss
|
|
US20230270818A1
(en)
|
2021-11-02 |
2023-08-31 |
University Of Rochester |
Tcf7l2 mediated remyelination in the brain
|
|
EP4472648A1
(en)
|
2022-02-01 |
2024-12-11 |
University of Rochester |
Methods of generating a population of neurons from human glial progenitor cells and genetic constructs for carrying out such methods
|
|
WO2023172514A1
(en)
|
2022-03-07 |
2023-09-14 |
Catamaran Bio, Inc. |
Engineered immune cell therapeutics targeted to her2 and methods of use thereof
|
|
WO2023215455A1
(en)
|
2022-05-05 |
2023-11-09 |
University Of Rochester |
Dual macroglial-microglial approach towards therapeutic cell replacement in neurodegenerative and neuropsychiatric disease
|
|
WO2024006911A1
(en)
|
2022-06-29 |
2024-01-04 |
FUJIFILM Holdings America Corporation |
Ipsc-derived astrocytes and methods of use thereof
|
|
US20240139256A1
(en)
|
2022-09-30 |
2024-05-02 |
FUJIFILM Cellular Dynamics, Inc. |
Methods for the production of cardiac fibroblasts
|
|
EP4658294A2
(en)
|
2023-02-02 |
2025-12-10 |
University of Rochester |
Competitive replacement of glial cells
|
|
WO2024192329A1
(en)
|
2023-03-16 |
2024-09-19 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods for producing stable human chondroctyes and their use for promoting cartillage growth and repair
|
|
WO2025245202A1
(en)
|
2024-05-21 |
2025-11-27 |
FUJIFILM Cellular Dynamics, Inc. |
Particle counting and biomass measurements of aggregated cell compositions
|